{"news_desk": "Editorial", "print_page": "10", "section_name": "Opinion", "subsection_name": "Sunday Review", "byline": {"original": "By THE EDITORIAL BOARD", "person": [], "organization": "THE EDITORIAL BOARD"}, "abstract": "Editorial criticizes pharmaceutical companies for maximizing their profits by pushing for astronomical prices on their products; notes that while Turing Pharmaceuticals and Valeant Pharmaceuticals are two of worst offenders in industry, many other drug makers have also set high prices that are hard to justify.", "type_of_material": "Editorial", "word_count": "499", "lead_paragraph": "Prices in many cases far exceed what\u2019s needed to cover the costs of research and clinical trials.", "pub_date": "2015-12-20T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "No Justification for High Drug Prices", "content_kicker": "Editorial", "print_headline": "No Justification for High Drug Prices", "kicker": "Editorial"}, "snippet": "Prices in many cases far exceed what\u2019s needed to cover the costs of research and clinical trials.", "multimedia": [{"height": 126, "url": "images/2015/12/20/opinion/20sun2web/20sun2web-thumbWide-v2.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2015/12/20/opinion/20sun2web/20sun2web-thumbWide-v2.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 402, "url": "images/2015/12/20/opinion/20sun2web/20sun2web-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "402", "xlarge": "images/2015/12/20/opinion/20sun2web/20sun2web-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2015/12/20/opinion/20sun2web/20sun2web-thumbStandard-v2.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2015/12/20/opinion/20sun2web/20sun2web-thumbStandard-v2.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2015/12/20/opinion/sunday/no-justification-for-high-drug-prices.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Editorials", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "3", "is_major": "Y", "value": "Turing Pharmaceuticals AG", "name": "organizations"}, {"rank": "4", "is_major": "N", "value": "Health Insurance and Managed Care", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Prices (Fares, Fees and Rates)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Kaiser Family Foundation", "name": "organizations"}, {"rank": "7", "is_major": "Y", "value": "Drugs (Pharmaceuticals)", "name": "subject"}], "blog": [], "_id": "5675b04338f0d82604f3631a", "source": "The New York Times"}